Determinants of Change in Total Cholesterol and HDL-C With Age: The Framingham Study
1994/11/01 by Peter W.F. Wilson, P. W. F. Wilson, K. M. Anderson +6 · 29 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Diabetes, Cardiovascular Risks, and Lipoproteins #Cancer, Lipids, and Metabolism #Cancer Risks and Factors
paper · doi:10.1093/geronj/49.6.m252
Abstract
OBJECTIVE: The purpose of the study was to assess the determinants of change of total cholesterol and high density lipoprotein cholesterol (HDL-C) change in an adult population. METHODS: The prospective cohort was examined at baseline and eight years later. A total of 2,222 men and 2,677 women age 20-79 years at baseline were included. Analyses were performed in 15-year age groups, and persons with cardiovascular disease or cancer during the observation period were excluded. RESULTS: In longitudinal analyses, body mass index (BMI) and plasma total cholesterol levels of each rose in concert among younger age groups, whereas levels declined in older individuals. Mean levels of BMI and total cholesterol peaked at a later age in women than in men. The corresponding changes in HDL-C were negative at all ages, and greater declines were seen in the elderly. A decrease in plasma total cholesterol was highly associated with greater age and a decrease in body mass index over the study interval, whereas the decline in HDL-C was proportional to change in body mass index. These changes remained significant after adjustment for baseline age and change in alcohol intake, cigarette consumption, diuretic use, and oral estrogen use. CONCLUSIONS: The rise in plasma total cholesterol among apparently healthy young men and women and its fall in the elderly are significantly associated with similar trends for obesity. The key determinants of a decline in HDL-C are an increase in obesity and advancing age itself. A decline in total cholesterol and in HDL-C is particularly common among the elderly, and it can be expected to occur without specific dietary or pharmacologic intervention.
Cited by
- Repurposing drugs to fight aging: The difficult path from bench to bedside
- The influence of cholesterol on the 5-year all-cause mortality of Parkinson patients with or without deep brain stimulation
- Estimating the Health, Economic, and Social Benefits of Obesity Treatment Using Microsimulation Modeling
- Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum
- High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. [europepmc]
- Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women. [europepmc]
- C-reactive protein and lipid parameters in older persons aged 80 years and older. [europepmc]
- Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia. [europepmc]
- Plasma biomarkers of mouse aging. [europepmc]
- Age-Related Changes in Biomarkers: Longitudinal Data from a Population-Based Sample. [europepmc]
- Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity. [europepmc]
- Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice. [europepmc]
- Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study. [europepmc]
- The effect of cardiorespiratory fitness on age-related lipids and lipoproteins. [europepmc]
- Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease. [europepmc]
- Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes. [europepmc]
- Low HDL levels in sepsis versus trauma patients in intensive care unit. [europepmc]
- Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromsø Study 1979-2016. [europepmc]
- Postprandial Metabolic Responses Differ by Age Group and Physical Activity Level. [europepmc]
- Evaluation of the Concurrent Trajectories of Cardiometabolic Risk Factors in the 14 Years Before Dementia. [europepmc]
- Decrease in HDL-C is Associated with Age and Household Income in Adults from the Korean National Health and Nutrition Examination Survey 2017: Correlation Analysis of Low HDL-C and Poverty. [europepmc]
- Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the Atherosclerosis Risk in Communities Study. [europepmc]
- Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population. [europepmc]
- Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007-2016. [europepmc]
- Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies. [europepmc]
- Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans. [europepmc]
- Plasma lipid profiles in early adulthood are associated with epigenetic aging in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. [europepmc]
- A negative association between total cholesterol and bone mineral density in US adult women. [europepmc]
- Metabonomic Biomarkers of Plaque Burden and Instability in Patients With Coronary Atherosclerotic Disease After Moderate Lipid-Lowering Therapy. [europepmc]
Related